Healthcare audit checklist template
Medication Safety Checklist
Audit medication safety across reconciliation, prescribing, storage, preparation, administration, high-alert medicines, monitoring, patient communication, transitions of care, incidents, near misses, corrective actions, and system learning.
Are the sampled medication orders, preparation, administration, and monitoring controls being followed with no immediate risk of medication-related harm?
Clinical Lead · Due immediately · Contain risk and obtain pharmacy/medical review
Select an answer to preview the workflow.
About this checklist
What a medication safety checklist should help you verify
Confirm that the medication-use system protects patients from avoidable harm from reconciliation through prescribing, storage, preparation, administration, monitoring, transitions, and incident learning.
When
Routine medication audits, transitions, high-risk reviews, and post-incident follow-up
Use it for unit safety rounds, pharmacy-clinical reviews, medication reconciliation audits, high-alert medicine checks, transitions of care, error follow-up, and corrective-action verification.
Who
Clinical teams, pharmacy, medication-safety leads, and quality reviewers
Prescribers, pharmacists, nurses, medication-safety staff, quality teams, department leaders, and authorized reviewers can collect or verify evidence.
Outcome
Traceable medication risk control
Create a consistent record of reconciliation, orders, storage, preparation, administration, high-alert safeguards, monitoring, patient communication, incidents, and corrective closure.
Complete medication safety checklist
Ten focused sections for a complete medication-safety review
Sixty practical checks across governance, reconciliation, prescribing, storage, preparation, administration, high-alert medicines, monitoring, patient communication, transitions, incident learning, and corrective closure. Adapt it to current law, accreditation requirements, formulary rules, facility policies, clinical protocols, patient population, pharmacy practice, and local reporting requirements.
Section 1Audit setup, medication-safety governance, scope, roles, and immediate-risk criteria
- Confirm the facility, department or service, audit date and shift, auditor, medication-safety lead, pharmacy contact, clinical owner, and escalation contacts.
- Define the patient-care areas, medication-use stages, patient groups, high-risk medicines, transitions of care, and sample period included in the review.
- Verify current medication-management policies, formularies, approved abbreviations, high-alert medicine safeguards, allergy processes, and local requirements are accessible to staff.
- Review recent medication errors, adverse drug events, near misses, omissions, reconciliation discrepancies, high-alert incidents, and overdue corrective actions relevant to the audited area.
- Confirm staff know how to stop or contain an immediate medication risk, obtain urgent clinical or pharmacy review, report an event, and escalate a serious safety concern.
- Capture the audit scope and evidence without recording unnecessary patient-identifying information, and use the organization's approved privacy and documentation practices.
Section 3Prescribing and order entry, indication, dose, route, frequency, patient factors, and clarification
- Review sampled medication orders for complete and unambiguous patient, medicine, dose, route, frequency or timing, and other information required by facility policy.
- Check the prescriber considered documented allergies, current medicines, duplication, interactions, contraindications, relevant laboratory results, and patient-specific factors when required.
- Verify dose, route, formulation, concentration, infusion instructions, duration, and maximum limits are appropriate for the intended medication and patient under the applicable clinical protocol.
- Confirm weight-based, renal, hepatic, pediatric, geriatric, oncology, or other patient-specific dosing calculations are checked using the organization's approved process when applicable.
- Check unclear, incomplete, conflicting, illegible, or unusual orders are clarified with an authorized prescriber before dispensing or administration rather than interpreted by assumption.
- Review overrides, verbal or telephone orders, urgent orders, order-set exceptions, and decision-support bypasses for required authorization, documentation, and follow-up.
Section 5Medication preparation, compounding, labeling, calculations, syringes, infusions, and aseptic controls
- Observe sampled medication preparation and verify the correct medicine, formulation, strength, dose, diluent, concentration, and final volume are selected according to the authorized order.
- Confirm calculations and conversions are performed using the organization's approved method and independently verified when required by policy or the medicine's risk controls.
- Verify medicines transferred from original packaging to another container are labeled as required, especially when they are not administered immediately after preparation.
- Check prepared syringes, infusion bags, cups, basins, or other medication containers remain traceable to the medicine and intended use according to facility labeling requirements.
- Confirm aseptic preparation, vial and ampule handling, needle and syringe use, injection-site preparation, and single-use versus multi-dose practices follow current facility infection-prevention procedures.
- Escalate wrong concentration, unclear labeling, suspected contamination, calculation discrepancy, preparation outside authorized conditions, or another issue that could cause medication harm before administration.
Section 7High-alert medicines, anticoagulants, insulin, opioids, concentrated electrolytes, and risk-specific safeguards
- Verify the organization maintains a current list of high-alert or high-risk medicines relevant to its services and defines specific safeguards for ordering, storage, preparation, administration, and monitoring.
- Check insulin processes address formulation, concentration, dose measurement, timing with nutrition where relevant, glucose monitoring, and independent verification or other safeguards required by policy.
- Review anticoagulant therapy for appropriate patient assessment, dose selection, relevant laboratory or clinical monitoring, interaction review, education, and bleeding-risk escalation according to the facility protocol.
- Check opioid processes address dose selection, prior exposure when relevant, sedation or respiratory-risk assessment, monitoring, co-administered sedatives, rescue-agent availability, and escalation criteria.
- Verify concentrated electrolytes and other high-risk injectable products are standardized, restricted, stored, prepared, and administered using the organization's approved risk-reduction strategy.
- Review high-alert medication overrides, rescue use, administration delays, monitoring failures, near misses, and adverse events for rapid learning and system-level corrective action.
Section 9Patient and caregiver communication, education, self-administration, discharge medicines, and handover
- Verify patients or caregivers receive medication information appropriate to their needs, including medicine purpose, significant changes, key precautions, and what to do if a problem occurs.
- Check high-risk discharge medicines receive the additional counseling, written information, monitoring plan, or follow-up required by the organization's policy.
- Confirm medication changes, stopped medicines, new medicines, dose changes, and outstanding monitoring are communicated clearly during discharge or transfer.
- Verify the medication list provided at discharge or transfer is reconciled with the current plan and is usable by the patient, caregiver, and next care provider as applicable.
- Check patient self-administration, bedside medicines, personal medicines brought from home, and patient-controlled therapy are governed by the organization's approved assessment and control process.
- Use teach-back, interpreter services, accessible formats, caregiver involvement, or other communication supports when required to reduce misunderstanding of the medication plan.
Section 2Medication history, reconciliation, allergies, transitions of care, and discrepancy resolution
- Verify the organization obtains the medication information required by its reconciliation process at admission, transfer, discharge, or other defined transitions of care.
- Confirm the medication history includes the information needed by the organization to compare current therapy with new orders, such as medication name and other required regimen details.
- Check documented allergies, intolerances, and previous serious adverse drug reactions are visible to the clinicians responsible for prescribing, dispensing, and administration.
- Verify medication discrepancies such as omissions, duplications, unintended continuation, unintended discontinuation, or conflicting doses are identified and resolved by an authorized clinician.
- Confirm medication changes made during transfer or discharge are communicated in a form useful to the next care team and, where appropriate, to the patient or caregiver.
- Review unresolved or repeatedly occurring reconciliation discrepancies for process gaps involving information sources, handoff quality, workload, documentation, or accountability.
Section 4Medication storage, security, expiry, temperature, high-alert medicines, and look-alike/sound-alike controls
- Inspect medication storage areas for secure access, orderly organization, cleanliness, adequate lighting, and separation from food, specimens, chemicals, or other incompatible materials.
- Verify medicines requiring controlled temperature are stored and monitored according to manufacturer instructions, pharmacy policy, and applicable local requirements, with excursions handled through the approved process.
- Check expired, recalled, damaged, contaminated, discontinued, returned, or otherwise non-usable medicines are identified and segregated so they cannot be selected accidentally.
- Confirm high-alert or high-risk medicines are identified and stored with the additional safeguards defined by the organization, including restricted access or standardized storage where required.
- Check look-alike/sound-alike medicines, different strengths, concentrated formulations, and similar packaging are managed using the organization's approved differentiation and storage strategies.
- Verify emergency, crash-cart, antidote, reversal-agent, and other critical medicines included in the facility program are available, within expiry, secured appropriately, and replenished after use.
Section 6Medication administration, patient identification, bedside checks, documentation, and interruption control
- Observe sampled medication administration and verify patient identity using the organization's approved identification process before the medicine is given.
- Confirm the medicine, dose, route, timing, indication, allergy status, and required pre-administration assessment or monitoring are checked according to facility policy.
- Verify barcode medication administration or other electronic verification is used as designed when available, and workarounds or overrides are investigated when they become routine.
- Check required independent verification for selected high-risk medicines or calculations is truly independent and documented according to organizational policy.
- Confirm medication administration is documented promptly and accurately, including omissions, refusals, held doses, PRN indications and effects, and other required information.
- Observe the medication round environment for avoidable interruptions, distractions, multi-tasking, unsafe batch preparation, unsecured medicines, or other workflow conditions that increase error risk.
Section 8Monitoring, therapeutic response, adverse reactions, laboratory follow-up, interactions, and rescue readiness
- Confirm medicines requiring laboratory, physiological, or clinical monitoring have the required tests, observations, and follow-up scheduled and reviewed within the appropriate timeframe.
- Check renal function, hepatic function, electrolytes, blood counts, coagulation results, glucose, drug levels, ECGs, or other relevant monitoring are reviewed when required by the medicine or patient condition.
- Verify PRN, sedating, pain, insulin, anticoagulant, antimicrobial, infusion, and other monitored therapies have documented response or effectiveness assessment when required.
- Confirm suspected adverse drug reactions, allergic reactions, toxicity, over-sedation, hypoglycemia, bleeding, infusion reactions, or other medication-related deterioration trigger prompt patient assessment and escalation.
- Check reversal agents, antidotes, rescue medicines, emergency response equipment, and escalation contacts required by the organization's medication-safety program are accessible and within readiness requirements.
- Review repeated monitoring omissions, delayed lab review, missed deterioration, interaction alerts, or duplicate therapy for system improvements in workflow, communication, or decision support.
Section 10Medication incidents, near misses, corrective actions, learning, trend review, and final sign-off
- Record medication-safety findings with the process stage, location, risk level, immediate containment, accountable owner, target date, and approved evidence without unnecessary patient identifiers.
- Verify medication errors, near misses, adverse drug events, omitted doses, wrong-patient risks, wrong-dose events, storage failures, and monitoring gaps are reported through the organization's required process.
- Confirm serious or recurring medication events receive contributing-factor, system, or root-cause review at the level required by organizational policy and applicable reporting rules.
- Create corrective actions that address the underlying system issue, such as storage design, labeling, staffing, technology, order sets, workflow, training, handoff, or monitoring, rather than relying only on reminders.
- Trend medication-safety events by medication, high-alert class, process stage, unit, shift, error type, contributing factor, severity, and recurrence to identify priorities for improvement.
- Record the final audit result, critical risks contained, open high-priority actions, next review date, medication-safety lead, clinical owner, auditor, reviewer, date, time, and sign-off.
Take it with you
Use the complete checklist during your next medication-safety review
Download the printable version, or continue below to see how the same medication-safety workflow can run with live audit evidence, critical-risk containment, corrective ownership, reinspection, and trend reporting in Taqtics.
How to use it
Turn medication safety into a visible audit and learning workflow
Review the medication-use process, sample high-risk controls, contain immediate patient risk first, assign corrective actions, and use errors and near misses to improve the system rather than only the individual event.
Set the medication-safety scope
Select the unit, medication-use stages, high-risk medicines, transitions, sample period, policies, recent incidents, and escalation contacts.
Observe and verify controls
Review reconciliation, orders, storage, preparation, administration, high-alert safeguards, monitoring, documentation, and patient communication.
Contain critical risk
Stop unsafe administration, clarify questionable orders, quarantine suspect medicines, obtain clinical/pharmacy review, and protect the patient immediately.
Learn and close
Assign actions, verify correction, review contributing factors, trend repeat events, and close findings only when the system control is evidenced.
Live interactive demo
See how a medication safety review works when it is run in Taqtics
Review a representative medication-safety control, flag a critical patient risk, attach non-identifying evidence, and create immediate clinical or pharmacy follow-up.
Assign reviews by facility, department, medication class, high-alert category, process stage, transition, shift, or safety theme.
Capture reconciliation, order, storage, preparation, administration, monitoring, incident, and corrective evidence without unnecessary patient identifiers.
Critical medication findings can create urgent clinical, pharmacy, and management actions with owners, due times, verification, and escalation.
Illustrative website demo. Responses are not stored or submitted.
Why digitize it
A clearer way to keep medication-safety risk visible across every care area
Taqtics connects reconciliation, order review, storage, preparation, administration, high-alert safeguards, monitoring, transitions, incidents, immediate containment, corrective actions, and recurring medication-risk trends.
Standardize medication-safety reviews
Use one audit structure across reconciliation, prescribing, storage, preparation, administration, monitoring, transitions, and incident follow-up.
Make critical medication risks visible
Assign wrong-patient, wrong-dose, high-alert, storage, monitoring, reconciliation, and transition risks to clinical and pharmacy owners immediately.
Close findings with proof
Capture clarified orders, corrected storage, updated labels, monitoring, education, policy changes, system fixes, and reviewer verification before closure.
Learn from errors and near misses
Compare medication events by process stage, high-alert class, unit, shift, contributing factor, severity, recurrence, and corrective-action aging.
Frequently asked questions
Medication safety checklist FAQs
What should a medication safety checklist include?+
A comprehensive checklist should cover governance, medication reconciliation, allergies, prescribing, storage, look-alike/sound-alike risks, high-alert medicines, preparation, labeling, administration, patient identification, monitoring, adverse reactions, patient education, transitions of care, errors, near misses, corrective actions, and system learning.
Why are transitions of care included in medication safety?+
WHO identifies transitions of care as one of the three priority action areas in Medication Without Harm. Medication discrepancies can occur when patients move between services or settings, so organizations need a structured process for accurate medication information and discrepancy resolution.
Which medicines should receive additional safeguards?+
Use the organization's own high-alert or high-risk medicine list and current professional guidance. ISMP defines high-alert medicines as drugs with a heightened risk of causing significant harm when used in error and recommends tailored safeguards such as standardized processes, restricted access, decision support, or independent verification where appropriate.
Should all high-alert medicines require a manual independent double check?+
No. ISMP notes that manual independent double checks are not always the optimal or practical strategy for every high-alert medicine. Organizations should select risk-reduction controls appropriate to the medicine, process, technology, and local policy.
What should happen after a medication error or near miss?+
Protect the patient first, obtain the required clinical or pharmacy assessment, document and report the event through the approved process, investigate contributing system factors at the level required, assign corrective actions, and verify that the control works before closure.
Does this checklist replace local medication policy, pharmacy standards, or accreditation requirements?+
No. It is a general operational audit template. Adapt it to current law, accreditation requirements, facility medication-management policies, formulary rules, pharmacy procedures, clinical protocols, patient population, high-alert medicine safeguards, privacy requirements, and local reporting rules.
Ready when you are
Run medication-safety checks with live evidence and accountable risk closure
Schedule reviews by facility, department, medication-use stage, high-alert class, transition, and shift, capture non-identifying evidence, contain critical risks, assign clinical and pharmacy owners, verify correction, and compare recurring medication-safety failures across every location.
Printable PDF · Free Taqtics trial · No credit card required